Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prometheus Biosciences Inc (NQ: RXDX ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 15, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 199.92 (9) Ask (Size) 199.99 (7) Prev. Close 199.92 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 41,700,063 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Shares of Exscientia Jumped on Wednesday July 12, 2023 The company may be riding the wave of an AI healthcare boom. Via The Motley Fool From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs July 07, 2023 Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... Via Benzinga Performance More News Read More Why Shares of Ventyx Biosciences Rose Monday July 03, 2023 Via The Motley Fool Is Merck Stock a Top Buy Right Now? June 19, 2023 Via The Motley Fool The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree June 02, 2023 Via Investor's Business Daily 3 Innovative Growth Stocks to Buy for Next-Gen Profits May 31, 2023 Via InvestorPlace RXDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Prometheus Biosciences, Inc. Is Fair to Shareholders May 24, 2023 From Halper Sadeh LLC Via Business Wire PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX May 22, 2023 From Kahn Swick & Foti, LLC Via Business Wire 3 Undervalued Pharma Stocks to Buy for High Total Returns May 19, 2023 Via InvestorPlace FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A May 16, 2023 Via Benzinga Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover May 16, 2023 Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 May 10, 2023 Via Benzinga Prometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress May 09, 2023 From Prometheus Biosciences Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth’s Inc. (Nasdaq – RUTH), Magenta Therapeutics, Inc. (Nasdaq – MGTA), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX) May 03, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR) May 01, 2023 From Brodsky & Smith LLC Via GlobeNewswire Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April April 30, 2023 Via Benzinga Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks? April 28, 2023 Via Investor's Business Daily Merck Makes a Bold Move That Could Transform Its Business April 27, 2023 Via The Motley Fool 3 Biotechs That Might Get Bought Out in 2023 April 26, 2023 Via The Motley Fool BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR) April 25, 2023 From Brodsky & Smith LLC Via GlobeNewswire This Supercharged Dividend King Stock Might Soon Run Out of Steam April 25, 2023 Via The Motley Fool PROMETHEUS BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX April 21, 2023 From Kahn Swick & Foti, LLC Via Business Wire Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review April 21, 2023 Via Investor's Business Daily Why Prometheus Biosciences Stock Is Skyrocketing This Week April 20, 2023 Via The Motley Fool Why This Nasdaq Stock Caught Fire This Week April 20, 2023 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.